Topics

Pharmaceutical Industry
SEC reviewing attempted takeover of Botox maker Allergan
SEC reviewing attempted takeover of Botox maker Allergan

The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management, said in an emailed statement Thursday that it has done nothing wrong in its effort to acquire Allergan. "We welcome the SEC's review of the facts," Pershing Square said. Last week, Allergan sued Valeant Pharmaceuticals International Inc. and Pershing Square, contending that the hedge fund violated securities laws by buying nearly 10% of its stock before announcing the attempted acquisition. SEC spokeswoman Florence...

Loading